These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2937942)

  • 21. [Further reasons to follow-up hepatitis B vaccination by means of an antibody test].
    Hall K; Struve J; Aronsson B; Frenning B; von Sydow M
    Lakartidningen; 1990 Jul; 87(30-31):2415. PubMed ID: 2144605
    [No Abstract]   [Full Text] [Related]  

  • 22. [Prevention of perinatal transmission of hepatitis B virus infection by HB-Ig and HB-vaccine].
    Ohryohji F; Umezu T; Ootsuka M; Kanda S
    Fukuoka Igaku Zasshi; 1984 Oct; 75(10):594-7. PubMed ID: 6240438
    [No Abstract]   [Full Text] [Related]  

  • 23. [Active immunoprophylaxis of type B viral hepatitis. Evaluation of the effectiveness of HEVAC-B vaccine in a population at risk].
    Tarocco RP; Faro G; Sargiotto A; Visconti C
    Minerva Med; 1987 Aug; 78(16):1233-41. PubMed ID: 2957614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Induction of HBs antibodies using a new genetically engineered vaccine].
    Just M; Berger R; Wegmann A; Glück R
    Schweiz Rundsch Med Prax; 1988 Dec; 77(51):1407-9. PubMed ID: 2975822
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy of hepatitis B vaccine.
    Campbell AD; Hambling MH; Pinnington PA; Lees E
    J Soc Occup Med; 1988; 38(1-2):46-7. PubMed ID: 2967403
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatitis B vaccination: how long does protection last?
    Laplanche A; Courouce AM; Jungers P; Benhamou E; Crosnier J
    Lancet; 1984 Oct; 2(8407):866. PubMed ID: 6148592
    [No Abstract]   [Full Text] [Related]  

  • 27. Hepatitis B vaccine in a hospital.
    Schaaff DM; Lender M; Snedeker P; Graham LA
    Ann Intern Med; 1984 Nov; 101(5):720-1. PubMed ID: 6237600
    [No Abstract]   [Full Text] [Related]  

  • 28. Anamnestic response to hepatitis B vaccine.
    Fay OH; Tanno H; Perez V; Palazzi J
    Lancet; 1985 Mar; 1(8429):647. PubMed ID: 2857990
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatitis B vaccination and idiopathic haemochromatosis.
    Saddi RS; Ebelin P; Pouliquen A; Gautreau C; Durand J; Jammet P; Courouce AM; Brechot C; Franco D; Thibult N
    Lancet; 1985 Nov; 2(8463):1061-2. PubMed ID: 2865532
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatitis B immunisation.
    Segal GR
    Med J Aust; 1991 Jan; 154(1):70-1. PubMed ID: 1824604
    [No Abstract]   [Full Text] [Related]  

  • 31. [Long-term observation on the immunogenicity of hepatitis B vaccine in infants and adults].
    Hayashi J; Kashiwagi S; Nomura H; Kajiyama W; Ikematsu H; Shingu T
    Kansenshogaku Zasshi; 1986 Jul; 60(7):659-65. PubMed ID: 3097205
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunogenicity and safety of hepatitis B virus vaccine].
    Hayashi J; Kashiwagi S; Nomura H; Kajiyama W; Ikematsu H; Aoyama T
    Kansenshogaku Zasshi; 1985 Oct; 59(10):970-6. PubMed ID: 3936888
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunogenicity of hepatitis B vaccine in children with sickle cell anemia.
    Sarnaik SA; Merline JR; Bond S
    J Pediatr; 1988 Mar; 112(3):429-30. PubMed ID: 2964517
    [No Abstract]   [Full Text] [Related]  

  • 34. Hepatitis B vaccine with and without polymerised albumin receptors.
    Coursaget P; Barres JL; Chiron JP; Adamowicz P
    Lancet; 1985 May; 1(8438):1152-3. PubMed ID: 2860351
    [No Abstract]   [Full Text] [Related]  

  • 35. Immune response to hepatitis B vaccine in hemodialysis patients.
    van Geelen JA; Schalm SW; de Visser EM; Heijtink RA
    Nephron; 1987; 45(3):216-8. PubMed ID: 2952895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgG subclass deficiency in patients with Down's syndrome and aberrant hepatitis B vaccine response.
    Avanzini MA; Söderström T; Wahl M; Plebani A; Burgio GR; Hanson LA
    Scand J Immunol; 1988 Oct; 28(4):465-70. PubMed ID: 2973659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancing suboptimal responses to hepatitis B vaccine.
    Pead PJ
    J Infect; 1987 Sep; 15(2):193-4. PubMed ID: 2959726
    [No Abstract]   [Full Text] [Related]  

  • 38. Skin testing to predict immune response to hepatitis B vaccine.
    Torre D; Maggiolo F; Broggini M; Botta V
    Lancet; 1985 Oct; 2(8458):783-4. PubMed ID: 2864518
    [No Abstract]   [Full Text] [Related]  

  • 39. Hepatitis B vaccine and haemodialysis.
    Lancet; 1984 Oct; 2(8409):962-3. PubMed ID: 6149347
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasma-derived vs recombinant hepatitis B vaccine.
    Gerety RJ; Ellis RW
    JAMA; 1987 Sep; 258(11):1474. PubMed ID: 2957518
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.